OroScience and ACE Surgical Supply ink distribution agreement for Periogenix

Periogenix is a new oral wound dressing technology that is intended to protect injured periodontal tissue (gums) by forming a temporary physical barrier to avoid further irritation. Periogenix helps clinicians manage oral wounds by providing a barrier to assist in the process of acute and chronic wound healing. Clinical and animal studies demonstrate that Periogenix protects and safely promotes the healing of post-operative surgical wounds.

“ACE Surgical’s highly trained marketing and sales organization is a natural fit to market and distribute Periogenix to dentists and dental specialists in the North American dental market,” said Phil Houle, chief operating officer of OroScience.

Mark Fontenot, ME, MBA, DDS, CEO of OroScience, added: “ACE Surgical’s proven track record of successfully selling leading edge dental technologies coupled with its access to the 100,000 plus dental offices in North America provides the potential to substantially penetrate the market for Periogenix.”

“Proper wound healing is a critical aspect of oral surgical procedures,” said Dr Bryan Pearson, a periodontist practicing in Lafayette, LA, USA. “Our clinical experience has shown that post-surgical wounds treated with Periogenix appear to be in an advanced state of healing and we’re now expanding its use in our surgical practice.”

“ACE Surgical Supply has been on the cutting edge of dental surgery advances for over 40 years, and we pride ourselves on careful evaluation combined with a constant search to provide our loyal customers with products to help enhance their practice and patient outcomes,” said Craig Carchidi, president of ACE Surgical. “We are very excited to partner with the team at OroScience and introduce Periogenix to the market.”

More information is available from ACE Surgical Supply and OroScience.